• New Painkillers Reduce Overdose Risk

  Ninety-one Americans die every day from opioid overdoses—deaths caused when opiates like oxycontin, heroin and fentanyl slow and eventually stop a person’s breathing.

• Potential New Autism Drug Shows Promise in Mice

  “This drug candidate is poised to go into clinical trials, and we think it might be effective against multiple forms of autism."

• Ozanimod Successful in Clinical Trials for Multiple Sclerosis

  "The success of ozanimod shows that academia and the NIH can make transforming discoveries that benefit patients and those that care for them."

• 

  Researchers Discover Promising New Anticancer Strategy

  Scientists at Scripps Research have discovered a compound that in laboratory tests irreversibly stops the growth of certain aggressive, treatment-resistant tumor cells.

• Scripps Florida Scientists Unveil ‘Roadmap’ to Aid Osteoporosis Treatment Development

  "Because of our aging population, these kinds of therapeutics are in great demand..."

• Researchers Explore Ways That a Drug Like Avandia Can Be Made Safer

  The insights could help researchers design new drugs with better efficacy and fewer side effects.

• Researchers Get a Lead on How to Detect Degenerative Neurological Diseases Sooner

  A new peptide probe may hold the key to better understanding amyloid diseases.

• Scripps Florida Scientists Identify Compounds That Significantly Increase Healthy Aging

  Scientists from the Florida campus of The Scripps Research Institute have identified a class of compounds that significantly delays the onset of several age-related symptoms

• Researchers Find A Way to Combat Pharmacoterrorism

  New method provides researchers with a new way to understand such drug compounds, especially where individual components or metabolites interact to produce the complete effects of psychoactive species.

• 

  The Scripps Research Institute and ShangPharma Innovation Announce Translational Research Collaboration

  World-class research institute and new innovation center partner to accelerate early translational research.